Calidi Biotherapeutics (CLDI) has issued an announcement.
Calidi Biotherapeutics, Inc. has boosted the compensation package for executive Wendy Pizarro. As of May 13, 2024, her annual salary rose by $25,000 to $425,000, and her potential bonus increased to 40% of her base salary. Additionally, she stands to receive a $120,000 bonus if the company secures a $10 million funding round by the end of the year, with the CEO determining the final bonus based on her contribution.
For an in-depth examination of CLDI stock, go to TipRanks’ Stock Analysis page.
